Part 1
Part 2
Part 3
Part 5
Pelvic congestion syndrome is a condition that causes pain in the pelvic region. This pain occurs mostly due to problems in the veins near the pelvic area. Pelvic congestion syndrome is a common gynecological condition in women that leads to often severe chronic pelvic pain. The causes of pelvic congestion syndrome generally involves pelvic inflammatory disease, endometriosis, pelvic varicosities and other conditions. Mostly in hospitals, pelvic congestion syndrome diagnosis is generally performed by venography. Prior to venogram, a pelvic ultrasound or other imaging study is performed to check any abnormalities. Market Analysis and Insights: Global and United States Pelvic Congestion Syndrome Treatment Market
This report focuses on global and United States Pelvic Congestion Syndrome Treatment market, also covers the segmentation data of other regions in regional level and county level. Due to the COVID-19 pandemic, the global Pelvic Congestion Syndrome Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) accounting for % of the Pelvic Congestion Syndrome Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Primary Pelvic Congestion Syndrome was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Pelvic Congestion Syndrome Treatment market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Pelvic Congestion Syndrome Treatment Scope and Market Size Pelvic Congestion Syndrome Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pelvic Congestion Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Pelvic Congestion Syndrome Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) Dihydroergotamine Progestins Others Segment by Application Primary Pelvic Congestion Syndrome Secondary Pelvic Congestion Syndrome By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE By Company Sanofi TOLMAR Actiza Pharmaceutical Pfizer Debiopharm Group AbbVie AstraZeneca Novartis Indivior Johnson and Johnson Fresenius Kabi TerSera Therapeutics Takeda Ferring
1 Study Coverage
1.1 Pelvic Congestion Syndrome Treatment Product Introduction
1.2 Global Pelvic Congestion Syndrome Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pelvic Congestion Syndrome Treatment Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pelvic Congestion Syndrome Treatment Sales in Volume for the Year 2017-2028
1.3 United States Pelvic Congestion Syndrome Treatment Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pelvic Congestion Syndrome Treatment Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pelvic Congestion Syndrome Treatment Sales in Volume for the Year 2017-2028
1.4 Pelvic Congestion Syndrome Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pelvic Congestion Syndrome Treatment in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pelvic Congestion Syndrome Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pelvic Congestion Syndrome Treatment Market Dynamics
1.5.1 Pelvic Congestion Syndrome Treatment Industry Trends
1.5.2 Pelvic Congestion Syndrome Treatment Market Drivers
1.5.3 Pelvic Congestion Syndrome Treatment Market Challenges
1.5.4 Pelvic Congestion Syndrome Treatment Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pelvic Congestion Syndrome Treatment Market Segment by Type
2.1.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
2.1.2 Dihydroergotamine
2.1.3 Progestins
2.1.4 Others
2.2 Global Pelvic Congestion Syndrome Treatment Market Size by Type
2.2.1 Global Pelvic Congestion Syndrome Treatment Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pelvic Congestion Syndrome Treatment Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pelvic Congestion Syndrome Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pelvic Congestion Syndrome Treatment Market Size by Type
2.3.1 United States Pelvic Congestion Syndrome Treatment Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pelvic Congestion Syndrome Treatment Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pelvic Congestion Syndrome Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pelvic Congestion Syndrome Treatment Market Segment by Application
3.1.1 Primary Pelvic Congestion Syndrome
3.1.2 Secondary Pelvic Congestion Syndrome
3.2 Global Pelvic Congestion Syndrome Treatment Market Size by Application
3.2.1 Global Pelvic Congestion Syndrome Treatment Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pelvic Congestion Syndrome Treatment Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pelvic Congestion Syndrome Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pelvic Congestion Syndrome Treatment Market Size by Application
3.3.1 United States Pelvic Congestion Syndrome Treatment Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pelvic Congestion Syndrome Treatment Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pelvic Congestion Syndrome Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pelvic Congestion Syndrome Treatment Competitor Landscape by Company
4.1 Global Pelvic Congestion Syndrome Treatment Market Size by Company
4.1.1 Top Global Pelvic Congestion Syndrome Treatment Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pelvic Congestion Syndrome Treatment Revenue by Manufacturer (2017-2022)
4.1.3 Global Pelvic Congestion Syndrome Treatment Sales by Manufacturer (2017-2022)
4.1.4 Global Pelvic Congestion Syndrome Treatment Price by Manufacturer (2017-2022)
4.2 Global Pelvic Congestion Syndrome Treatment Concentration Ratio (CR)
4.2.1 Pelvic Congestion Syndrome Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pelvic Congestion Syndrome Treatment in 2021
4.2.3 Global Pelvic Congestion Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pelvic Congestion Syndrome Treatment Manufacturing Base Distribution, Product Type
4.3.1 Global Pelvic Congestion Syndrome Treatment Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pelvic Congestion Syndrome Treatment Product Type
4.3.3 Date of International Manufacturers Enter into Pelvic Congestion Syndrome Treatment Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pelvic Congestion Syndrome Treatment Market Size by Company
4.5.1 Top Pelvic Congestion Syndrome Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pelvic Congestion Syndrome Treatment Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pelvic Congestion Syndrome Treatment Sales by Players (2020, 2021 & 2022)
5 Global Pelvic Congestion Syndrome Treatment Market Size by Region
5.1 Global Pelvic Congestion Syndrome Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pelvic Congestion Syndrome Treatment Market Size in Volume by Region (2017-2028)
5.2.1 Global Pelvic Congestion Syndrome Treatment Sales in Volume by Region: 2017-2022
5.2.2 Global Pelvic Congestion Syndrome Treatment Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pelvic Congestion Syndrome Treatment Market Size in Value by Region (2017-2028)
5.3.1 Global Pelvic Congestion Syndrome Treatment Sales in Value by Region: 2017-2022
5.3.2 Global Pelvic Congestion Syndrome Treatment Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pelvic Congestion Syndrome Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Pelvic Congestion Syndrome Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pelvic Congestion Syndrome Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pelvic Congestion Syndrome Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Pelvic Congestion Syndrome Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Pelvic Congestion Syndrome Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pelvic Congestion Syndrome Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Pelvic Congestion Syndrome Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pelvic Congestion Syndrome Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pelvic Congestion Syndrome Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Pelvic Congestion Syndrome Treatment Products Offered
7.1.5 Sanofi Recent Development
7.2 TOLMAR
7.2.1 TOLMAR Corporation Information
7.2.2 TOLMAR Description and Business Overview
7.2.3 TOLMAR Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.2.4 TOLMAR Pelvic Congestion Syndrome Treatment Products Offered
7.2.5 TOLMAR Recent Development
7.3 Actiza Pharmaceutical
7.3.1 Actiza Pharmaceutical Corporation Information
7.3.2 Actiza Pharmaceutical Description and Business Overview
7.3.3 Actiza Pharmaceutical Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Actiza Pharmaceutical Pelvic Congestion Syndrome Treatment Products Offered
7.3.5 Actiza Pharmaceutical Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Pelvic Congestion Syndrome Treatment Products Offered
7.4.5 Pfizer Recent Development
7.5 Debiopharm Group
7.5.1 Debiopharm Group Corporation Information
7.5.2 Debiopharm Group Description and Business Overview
7.5.3 Debiopharm Group Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Debiopharm Group Pelvic Congestion Syndrome Treatment Products Offered
7.5.5 Debiopharm Group Recent Development
7.6 AbbVie
7.6.1 AbbVie Corporation Information
7.6.2 AbbVie Description and Business Overview
7.6.3 AbbVie Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.6.4 AbbVie Pelvic Congestion Syndrome Treatment Products Offered
7.6.5 AbbVie Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Corporation Information
7.7.2 AstraZeneca Description and Business Overview
7.7.3 AstraZeneca Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.7.4 AstraZeneca Pelvic Congestion Syndrome Treatment Products Offered
7.7.5 AstraZeneca Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Pelvic Congestion Syndrome Treatment Products Offered
7.8.5 Novartis Recent Development
7.9 Indivior
7.9.1 Indivior Corporation Information
7.9.2 Indivior Description and Business Overview
7.9.3 Indivior Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Indivior Pelvic Congestion Syndrome Treatment Products Offered
7.9.5 Indivior Recent Development
7.10 Johnson and Johnson
7.10.1 Johnson and Johnson Corporation Information
7.10.2 Johnson and Johnson Description and Business Overview
7.10.3 Johnson and Johnson Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Johnson and Johnson Pelvic Congestion Syndrome Treatment Products Offered
7.10.5 Johnson and Johnson Recent Development
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Corporation Information
7.11.2 Fresenius Kabi Description and Business Overview
7.11.3 Fresenius Kabi Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Fresenius Kabi Pelvic Congestion Syndrome Treatment Products Offered
7.11.5 Fresenius Kabi Recent Development
7.12 TerSera Therapeutics
7.12.1 TerSera Therapeutics Corporation Information
7.12.2 TerSera Therapeutics Description and Business Overview
7.12.3 TerSera Therapeutics Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.12.4 TerSera Therapeutics Products Offered
7.12.5 TerSera Therapeutics Recent Development
7.13 Takeda
7.13.1 Takeda Corporation Information
7.13.2 Takeda Description and Business Overview
7.13.3 Takeda Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Takeda Products Offered
7.13.5 Takeda Recent Development
7.14 Ferring
7.14.1 Ferring Corporation Information
7.14.2 Ferring Description and Business Overview
7.14.3 Ferring Pelvic Congestion Syndrome Treatment Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Ferring Products Offered
7.14.5 Ferring Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pelvic Congestion Syndrome Treatment Industry Chain Analysis
8.2 Pelvic Congestion Syndrome Treatment Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pelvic Congestion Syndrome Treatment Distributors
8.3 Pelvic Congestion Syndrome Treatment Production Mode & Process
8.4 Pelvic Congestion Syndrome Treatment Sales and Marketing
8.4.1 Pelvic Congestion Syndrome Treatment Sales Channels
8.4.2 Pelvic Congestion Syndrome Treatment Distributors
8.5 Pelvic Congestion Syndrome Treatment Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Pelvic Congestion Syndrome Treatment CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Pelvic Congestion Syndrome Treatment Market Trends Table 3. Pelvic Congestion Syndrome Treatment Market Drivers Table 4. Pelvic Congestion Syndrome Treatment Market Challenges Table 5. Pelvic Congestion Syndrome Treatment Market Restraints Table 6. Global Pelvic Congestion Syndrome Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Pelvic Congestion Syndrome Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Pelvic Congestion Syndrome Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Pelvic Congestion Syndrome Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Pelvic Congestion Syndrome Treatment Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Pelvic Congestion Syndrome Treatment Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Pelvic Congestion Syndrome Treatment Revenue Share by Manufacturer, 2017-2022 Table 13. Global Pelvic Congestion Syndrome Treatment Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Pelvic Congestion Syndrome Treatment Sales Share by Manufacturer, 2017-2022 Table 15. Global Pelvic Congestion Syndrome Treatment Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Pelvic Congestion Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Pelvic Congestion Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pelvic Congestion Syndrome Treatment as of 2021) Table 18. Top Players of Pelvic Congestion Syndrome Treatment in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Pelvic Congestion Syndrome Treatment Product Type Table 20. Date of International Manufacturers Enter into Pelvic Congestion Syndrome Treatment Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Pelvic Congestion Syndrome Treatment Players in United States Market, Ranking by Revenue (2021) Table 23. United States Pelvic Congestion Syndrome Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Pelvic Congestion Syndrome Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Pelvic Congestion Syndrome Treatment Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Pelvic Congestion Syndrome Treatment Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Pelvic Congestion Syndrome Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Pelvic Congestion Syndrome Treatment Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Pelvic Congestion Syndrome Treatment Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Pelvic Congestion Syndrome Treatment Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Pelvic Congestion Syndrome Treatment Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Pelvic Congestion Syndrome Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Pelvic Congestion Syndrome Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Pelvic Congestion Syndrome Treatment Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Pelvic Congestion Syndrome Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Pelvic Congestion Syndrome Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Pelvic Congestion Syndrome Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Pelvic Congestion Syndrome Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Pelvic Congestion Syndrome Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Pelvic Congestion Syndrome Treatment Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Pelvic Congestion Syndrome Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Sanofi Corporation Information Table 43. Sanofi Description and Business Overview Table 44. Sanofi Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Sanofi Pelvic Congestion Syndrome Treatment Product Table 46. Sanofi Recent Development Table 47. TOLMAR Corporation Information Table 48. TOLMAR Description and Business Overview Table 49. TOLMAR Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. TOLMAR Product Table 51. TOLMAR Recent Development Table 52. Actiza Pharmaceutical Corporation Information Table 53. Actiza Pharmaceutical Description and Business Overview Table 54. Actiza Pharmaceutical Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. Actiza Pharmaceutical Product Table 56. Actiza Pharmaceutical Recent Development Table 57. Pfizer Corporation Information Table 58. Pfizer Description and Business Overview Table 59. Pfizer Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Pfizer Product Table 61. Pfizer Recent Development Table 62. Debiopharm Group Corporation Information Table 63. Debiopharm Group Description and Business Overview Table 64. Debiopharm Group Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. Debiopharm Group Product Table 66. Debiopharm Group Recent Development Table 67. AbbVie Corporation Information Table 68. AbbVie Description and Business Overview Table 69. AbbVie Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. AbbVie Product Table 71. AbbVie Recent Development Table 72. AstraZeneca Corporation Information Table 73. AstraZeneca Description and Business Overview Table 74. AstraZeneca Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. AstraZeneca Product Table 76. AstraZeneca Recent Development Table 77. Novartis Corporation Information Table 78. Novartis Description and Business Overview Table 79. Novartis Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Novartis Product Table 81. Novartis Recent Development Table 82. Indivior Corporation Information Table 83. Indivior Description and Business Overview Table 84. Indivior Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. Indivior Product Table 86. Indivior Recent Development Table 87. Johnson and Johnson Corporation Information Table 88. Johnson and Johnson Description and Business Overview Table 89. Johnson and Johnson Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. Johnson and Johnson Product Table 91. Johnson and Johnson Recent Development Table 92. Fresenius Kabi Corporation Information Table 93. Fresenius Kabi Description and Business Overview Table 94. Fresenius Kabi Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. Fresenius Kabi Product Table 96. Fresenius Kabi Recent Development Table 97. TerSera Therapeutics Corporation Information Table 98. TerSera Therapeutics Description and Business Overview Table 99. TerSera Therapeutics Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. TerSera Therapeutics Product Table 101. TerSera Therapeutics Recent Development Table 102. Takeda Corporation Information Table 103. Takeda Description and Business Overview Table 104. Takeda Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. Takeda Product Table 106. Takeda Recent Development Table 107. Ferring Corporation Information Table 108. Ferring Description and Business Overview Table 109. Ferring Pelvic Congestion Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 110. Ferring Product Table 111. Ferring Recent Development Table 112. Key Raw Materials Lists Table 113. Raw Materials Key Suppliers Lists Table 114. Pelvic Congestion Syndrome Treatment Customers List Table 115. Pelvic Congestion Syndrome Treatment Distributors List Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Pelvic Congestion Syndrome Treatment Product Picture Figure 2. Global Pelvic Congestion Syndrome Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Pelvic Congestion Syndrome Treatment Market Size 2017-2028 (US$ Million) Figure 4. Global Pelvic Congestion Syndrome Treatment Sales 2017-2028 (K Units) Figure 5. United States Pelvic Congestion Syndrome Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Pelvic Congestion Syndrome Treatment Market Size 2017-2028 (US$ Million) Figure 7. United States Pelvic Congestion Syndrome Treatment Sales 2017-2028 (K Units) Figure 8. United States Pelvic Congestion Syndrome Treatment Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Pelvic Congestion Syndrome Treatment Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Pelvic Congestion Syndrome Treatment Report Years Considered Figure 11. Product Picture of NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) Figure 12. Product Picture of Dihydroergotamine Figure 13. Product Picture of Progestins Figure 14. Product Picture of Others Figure 15. Global Pelvic Congestion Syndrome Treatment Market Share by Type in 2022 & 2028 Figure 16. Global Pelvic Congestion Syndrome Treatment Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Pelvic Congestion Syndrome Treatment Sales Market Share in Value by Type (2017-2028) Figure 18. Global Pelvic Congestion Syndrome Treatment Sales by Type (2017-2028) & (K Units) Figure 19. Global Pelvic Congestion Syndrome Treatment Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Pelvic Congestion Syndrome Treatment Price by Type (2017-2028) & (US$/Unit) Figure 21. United States Pelvic Congestion Syndrome Treatment Market Share by Type in 2022 & 2028 Figure 22. United States Pelvic Congestion Syndrome Treatment Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Pelvic Congestion Syndrome Treatment Sales Market Share in Value by Type (2017-2028) Figure 24. United States Pelvic Congestion Syndrome Treatment Sales by Type (2017-2028) & (K Units) Figure 25. United States Pelvic Congestion Syndrome Treatment Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Pelvic Congestion Syndrome Treatment Price by Type (2017-2028) & (US$/Unit) Figure 27. Product Picture of Primary Pelvic Congestion Syndrome Figure 28. Product Picture of Secondary Pelvic Congestion Syndrome Figure 29. Global Pelvic Congestion Syndrome Treatment Market Share by Application in 2022 & 2028 Figure 30. Global Pelvic Congestion Syndrome Treatment Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Pelvic Congestion Syndrome Treatment Sales Market Share in Value by Application (2017-2028) Figure 32. Global Pelvic Congestion Syndrome Treatment Sales by Application (2017-2028) & (K Units) Figure 33. Global Pelvic Congestion Syndrome Treatment Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Pelvic Congestion Syndrome Treatment Price by Application (2017-2028) & (US$/Unit) Figure 35. United States Pelvic Congestion Syndrome Treatment Market Share by Application in 2022 & 2028 Figure 36. United States Pelvic Congestion Syndrome Treatment Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Pelvic Congestion Syndrome Treatment Sales Market Share in Value by Application (2017-2028) Figure 38. United States Pelvic Congestion Syndrome Treatment Sales by Application (2017-2028) & (K Units) Figure 39. United States Pelvic Congestion Syndrome Treatment Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Pelvic Congestion Syndrome Treatment Price by Application (2017-2028) & (US$/Unit) Figure 41. North America Pelvic Congestion Syndrome Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 42. North America Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. United States Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Pelvic Congestion Syndrome Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 46. Europe Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Pelvic Congestion Syndrome Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 53. Asia-Pacific Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. China Taiwan Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America Pelvic Congestion Syndrome Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 64. Latin America Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Colombia Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Pelvic Congestion Syndrome Treatment Sales in Volume Growth Rate 2017-2028 (K Units) Figure 70. Middle East & Africa Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. UAE Pelvic Congestion Syndrome Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Pelvic Congestion Syndrome Treatment Value Chain Figure 75. Pelvic Congestion Syndrome Treatment Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed
Pelvic congestion syndrome is a condition that causes pain in the pelvic region. This pain occurs mostly due to problems in the veins near the pelvic area. Pelvic congestion syndrome is a common gynecological condition in women that leads to often severe chronic pelvic pain. The causes of pelvic congestion syndrome generally involves pelvic inflammatory disease, endometriosis, pelvic varicosities and other conditions. Mostly in hospitals, pelvic congestion syndrome diagnosis is generally performed by venography. Prior to venogram, a pelvic ultrasound or other imaging study is performed to check any abnormalities. Market Analysis and Insights: Global and United States Pelvic Congestion Syndrome Treatment Market
This report focuses on global and United States Pelvic Congestion Syndrome Treatment market, also covers the segmentation data of other regions in regional level and county level. Due to the COVID-19 pandemic, the global Pelvic Congestion Syndrome Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) accounting for % of the Pelvic Congestion Syndrome Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Primary Pelvic Congestion Syndrome was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Pelvic Congestion Syndrome Treatment market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Pelvic Congestion Syndrome Treatment Scope and Market Size Pelvic Congestion Syndrome Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pelvic Congestion Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Pelvic Congestion Syndrome Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) Dihydroergotamine Progestins Others Segment by Application Primary Pelvic Congestion Syndrome Secondary Pelvic Congestion Syndrome By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE By Company Sanofi TOLMAR Actiza Pharmaceutical Pfizer Debiopharm Group AbbVie AstraZeneca Novartis Indivior Johnson and Johnson Fresenius Kabi TerSera Therapeutics Takeda Ferring
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now